ANTIBODIES

Contributor Information
- Name Ming-Qing Du
- Institute University College London (UCL)
Tool Details
- Tool name: Anti-BCL10 [151]
- Clone: 151
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; IHC ; WB
- Strain: Balb/c
- Description: BCL-10 is an apoptotic regulatory molecule, of approximately 31 kDa. It was identified through its direct involvement in t(1:14) (p22;q32) of mucosa-associated lymphoid tissue (MALT) lymphoma. In B-cell follicles, BCL10 has been shown to be expressed abundantly in the germinal center B cells, moderately in the marginal zone, but only weakly in mantle zone B cells. This differential expression is an indicator of its importance in maturation and malignant transformation of human B-cells. BCL-10 contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB.
- Immunogen: Full-length recombinant BCL-10 protein
- Isotype: IgG1 kappa
- Research area: Apoptosis and autophagy; Cancer; Cell signaling and signal transduction; Metabolism
- Myeloma used: NS0
- For Research Use Only
Target Details
- Target: Bcl10
- Target background: BCL-10 is an apoptotic regulatory molecule, of approximately 31 kDa. It was identified through its direct involvement in t(1:14) (p22;q32) of mucosa-associated lymphoid tissue (MALT) lymphoma. In B-cell follicles, BCL10 has been shown to be expressed abundantly in the germinal center B cells, moderately in the marginal zone, but only weakly in mantle zone B cells. This differential expression is an indicator of its importance in maturation and malignant transformation of human B-cells. BCL-10 contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB.
Application Details
- Application: ELISA ; IHC ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15ðC to -25ðC
- Shipping conditions: Shipping at 4ðC
Related Tools
References
- • Shen et al. 2003. Blood. 102(4):1553-4. PMID: 12900354.
- • Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma.
- • Ye et al. 2000. Am J Pathol. 157(4):1147-54. PMID: 11021819.
- • BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.
- • Du et al. 2000. Blood. 95(12):3885-90. PMID: 10845924.
- • BCL10 gene mutation in lymphoma.